Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 267

1.

Growing old, yet staying young: The role of telomeres in bats' exceptional longevity.

Foley NM, Hughes GM, Huang Z, Clarke M, Jebb D, Whelan CV, Petit EJ, Touzalin F, Farcy O, Jones G, Ransome RD, Kacprzyk J, O'Connell MJ, Kerth G, Rebelo H, Rodrigues L, Puechmaille SJ, Teeling EC.

Sci Adv. 2018 Feb 7;4(2):eaao0926. doi: 10.1126/sciadv.aao0926. eCollection 2018 Feb.

PMID:
29441358
2.

Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.

Rezk T, Gilbertson JA, Rowczenio D, Bass P, Lachmann HJ, Wechalekar AD, Fontana M, Mahmood S, Sachchithanantham S, Whelan CJ, Wong J, Rendell N, Taylor GW, Hawkins PN, Gillmore JD.

Nephrol Dial Transplant. 2018 Feb 1;33(2):241-247. doi: 10.1093/ndt/gfw375.

PMID:
29401357
3.

Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.

Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM.

Brain. 2018 Feb 1;141(2):391-408. doi: 10.1093/brain/awx341.

PMID:
29365066
4.

Rapid hematological responses improve outcomes in patients with very advanced (Stage IIIb) cardiac immunoglobulin light chain amyloidosis.

Manwani R, Foard D, Mahmood S, Sachchithanantham S, Lane T, Quarta C, Youngstein T, Rezk T, Lachmann HJ, Gillmore JD, Fontana M, Whelan C, Hawkins PN, Wechalekar AD.

Haematologica. 2018 Jan 5. pii: haematol.2017.178095. doi: 10.3324/haematol.2017.178095. [Epub ahead of print] No abstract available.

5.

A new staging system for cardiac transthyretin amyloidosis.

Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN.

Eur Heart J. 2017 Oct 18. doi: 10.1093/eurheartj/ehx589. [Epub ahead of print]

PMID:
29048471
6.

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G.

Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.170. [Epub ahead of print]

PMID:
29038599
7.

Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study.

Phillips EH, Nash S, Adedayo T, Whelan CJ, Fontana M, Mahmood S, Lachmann HJ, Gillmore JD, Smith P, Clifton-Hadley L, Hawkins PN, Wechalekar AD.

Amyloid. 2017 Dec;24(4):242-244. doi: 10.1080/13506129.2017.1385453. Epub 2017 Oct 6. No abstract available.

PMID:
28984490
8.

A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration.

Davies T, Saleh A, Coghlan G, Whelan C, Agarwal B.

J Intensive Care Soc. 2017 May;18(2):138-142. doi: 10.1177/1751143716682263. Epub 2016 Nov 29.

9.

Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia.

Kochunov P, Coyle TR, Rowland LM, Jahanshad N, Thompson PM, Kelly S, Du X, Sampath H, Bruce H, Chiappelli J, Ryan M, Fisseha F, Savransky A, Adhikari B, Chen S, Paciga SA, Whelan CD, Xie Z, Hyde CL, Chen X, Schubert CR, O'Donnell P, Hong LE.

JAMA Psychiatry. 2017 Sep 1;74(9):958-966. doi: 10.1001/jamapsychiatry.2017.2228.

PMID:
28768312
10.

Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.

Rezk T, Lachmann HJ, Fontana M, Sachchithanantham S, Mahmood S, Petrie A, Whelan CJ, Pinney JH, Foard D, Lane T, Youngstein T, Wechalekar AD, Bass P, Hawkins PN, Gillmore JD.

Kidney Int. 2017 Dec;92(6):1476-1483. doi: 10.1016/j.kint.2017.05.004. Epub 2017 Jul 18.

PMID:
28729034
11.

Magnetic Resonance in Transthyretin Cardiac Amyloidosis.

Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T, Rosmini S, Quarta CC, Whelan CJ, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M.

J Am Coll Cardiol. 2017 Jul 25;70(4):466-477. doi: 10.1016/j.jacc.2017.05.053.

PMID:
28728692
12.

ENIGMA-Viewer: interactive visualization strategies for conveying effect sizes in meta-analysis.

Zhang G, Kochunov P, Hong E, Kelly S, Whelan C, Jahanshad N, Thompson P, Chen J.

BMC Bioinformatics. 2017 Jun 6;18(Suppl 6):253. doi: 10.1186/s12859-017-1634-8.

13.

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.

Quarta CC, Gonzalez-Lopez E, Gilbertson JA, Botcher N, Rowczenio D, Petrie A, Rezk T, Youngstein T, Mahmood S, Sachchithanantham S, Lachmann HJ, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Gillmore JD.

Eur Heart J. 2017 Jun 21;38(24):1905-1908. doi: 10.1093/eurheartj/ehx047.

PMID:
28605421
14.

Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis.

Rezk T, Whelan CJ, Lachmann HJ, Fontana M, Sachchithanantham S, Mahmood S, Khan F, Khiani R, Tomson J, Youngstein T, Gillmore JD, Hawkins PN, Wechalekar AD.

Br J Haematol. 2017 May 9. doi: 10.1111/bjh.14747. [Epub ahead of print] No abstract available.

PMID:
28485005
15.

The impact of a structured clinical training course on interns' self-reported confidence with core clinical urology skills.

Browne C, Norton S, Nolan JM, Whelan C, Sullivan JF, Quinlan M, Sheikh M, Mc Dermott TED, Lynch TH, Manecksha RP.

Ir J Med Sci. 2018 Feb;187(1):255-260. doi: 10.1007/s11845-017-1616-x. Epub 2017 May 4.

PMID:
28474236
16.

A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.

Carter JP, Foard D, Rannigan L, Aliaz K, Mahmood S, Sachchithanantham S, Fontana M, Quarta C, Martinez De Azcona Naharro A, Youngstein T, Rezk T, Wechalekar A, Whelan C, Lachmann H, Hawkins P, Gillmore J, Lane T.

Amyloid. 2017 Mar;24(sup1):72-73. doi: 10.1080/13506129.2017.1295944. No abstract available.

PMID:
28434320
17.

"She's a dog at the end of the day": Guide dog owners' perspectives on the behaviour of their guide dog.

Craigon PJ, Hobson-West P, England GCW, Whelan C, Lethbridge E, Asher L.

PLoS One. 2017 Apr 19;12(4):e0176018. doi: 10.1371/journal.pone.0176018. eCollection 2017.

18.

CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.

Martinez-Naharro A, Abdel-Gadir A, Treibel TA, Zumbo G, Knight DS, Rosmini S, Lane T, Mahmood S, Sachchithanantham S, Whelan CJ, Lachmann HJ, Wechalekar AD, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M.

JACC Cardiovasc Imaging. 2018 Jan;11(1):152-154. doi: 10.1016/j.jcmg.2017.02.012. Epub 2017 Apr 12. No abstract available.

PMID:
28412427
19.

High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot study.

Mahmood S, Sovani M, Smith P, George L, Quarta CC, Sachchithanantham S, Fontana M, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.

Sleep Med. 2017 Apr;32:191-197. doi: 10.1016/j.sleep.2016.11.021. Epub 2016 Dec 21.

PMID:
28366333
20.

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis.

Wechalekar AD, Whelan C.

Blood Cancer J. 2017 Mar 24;7(3):e546. doi: 10.1038/bcj.2017.26. No abstract available.

Supplemental Content

Loading ...
Support Center